Impulse Dynamics

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Impulse Dynamics sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).

9 total trials 3 currently recruiting 3 completed top decile by trial count

Impulse Dynamics: 9 sponsored US clinical trials, 3 recruiting.

Impulse Dynamics sponsors 9 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 3 completed. The most-studied condition in this pipeline is Heart Failure, with 4 trials.

Top-decile sponsor footprint

Impulse Dynamics ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

What is open in the Impulse Dynamics pipeline

3 recruiting of 9 indexed (33% open); 3 completed (33%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Heart Failure (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Impulse Dynamics: open-pipeline peers nationwide

Peers matched on 9 registered trials and 33% open enrollment, not the therapeutic-area sidebar.

Impulse Dynamics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 246810 0%10%20%30%40%50% Total trials Recruiting share Impulse Dynamics4D Molecular Therapeutics9 Meters BiopharmaAadi BioscienceAblynx, a Sanofi companyAaron CookAbivax S.A.Actuated MedicalAdagio Medical
Impulse Dynamics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Impulse Dynamics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 9 trials (± recruiting share)

Sponsors near 33% open enrollment (± trial volume)

What to do with this Impulse Dynamics page

9 registered trials is a research-attention snapshot, not an endorsement of Impulse Dynamics or any single study.

  • 3 of Impulse Dynamics's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Heart Failure is the condition Impulse Dynamics studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Heart Failure trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Impulse Dynamics pipeline card: 9 registered trials from official public datasets.Report a data error.